menu search

Deciphera pharmaceuticals: clawing its way back

Deciphera Pharmaceuticals is focused on the development of their multikinase inhibitor ripretinib for the treatment of gastrointestinal stromal tumor....

August 22, 2023, 5:06 am

Aerami therapeutics to present pharmacokinetic data supporting aer-901 (inhaled imatinib) for pulmonary hypertension at the 2023 american thoracic society (ats) international conference

DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing ...

May 11, 2023, 12:00 pm

Aerovate: developing an exciting pah drug, initiating with a buy

Aerovate is a SMID-cap biotech developing an inhaled imatinib for pulmonary arterial hypertension. AV-1...

January 29, 2023, 7:12 am


Search within

Pages Search Results: